相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas
G. Ghilardi et al.
ANNALS OF ONCOLOGY (2022)
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape
Ye Li et al.
NATURE MEDICINE (2022)
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
May Daher et al.
BLOOD (2021)
Engineered off-the-shelf therapeutic T cells resist host immune rejection
Feiyan Mo et al.
NATURE BIOTECHNOLOGY (2021)
A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells
Upasana Sunil Arvindam et al.
LEUKEMIA (2021)
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Mehmet Kemal Samur et al.
NATURE COMMUNICATIONS (2021)
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies
Lucila N. Kerbauy et al.
CLINICAL CANCER RESEARCH (2021)
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma
Astrid Tschan-Plessl et al.
CYTOTHERAPY (2021)
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
Congcong Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia
Caroline Duault et al.
BLOOD (2021)
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
Karrune Woan et al.
CELL STEM CELL (2021)
Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma
Aimee M. Merino et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
Huang Zhu et al.
BLOOD (2020)
In Vivo Tracking of Adoptively Transferred Natural Killer Cells in Rhesus Macaques Using 89Zirconium-Oxine Cell Labeling and PET Imaging
Noriko Sato et al.
CLINICAL CANCER RESEARCH (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
Yu Yang Ng et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
Ester Lozano et al.
CLINICAL CANCER RESEARCH (2020)
MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies
Srividya Swaminathan et al.
NATURE COMMUNICATIONS (2020)
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals
Philippos Demetriou et al.
NATURE IMMUNOLOGY (2020)
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
Elizabeth L. Siegler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
Benjamin H. Goldenson et al.
FRONTIERS IN IMMUNOLOGY (2020)
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
Daniel A. Vallera et al.
CANCERS (2020)
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Alexandre V. Hirayama et al.
BLOOD (2019)
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
Mohamad Hamieh et al.
NATURE (2019)
Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
Melanie Maerklin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4R334X
Emily Levy et al.
FRONTIERS IN IMMUNOLOGY (2019)
Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control
Bartosz Grzywacz et al.
JOURNAL OF IMMUNOTHERAPY (2019)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley et al.
BLOOD ADVANCES (2019)
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL
Martin Felices et al.
BLOOD ADVANCES (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
Rizwan Romee et al.
BLOOD (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple Myeloma
Jinge Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells
Qing-Ming Wang et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
Dhifaf Sarhan et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Mica-129 Dimorphism and soluble Mica are associated With the Progression of Multiple Myeloma
Alessandra Zingoni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Acquired natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
Jodi Chiu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
Qing Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
Monica Parodi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
Dhifaf Sarha et al.
BLOOD ADVANCES (2018)
Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
Simin Kiany et al.
ONCOIMMUNOLOGY (2017)
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/ HER2-Positive Breast Cancer Analysis of the NSABP B-31 Trial
Patrick G. Gavin et al.
JAMA ONCOLOGY (2017)
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Veronika Kremer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
Zhongjuan Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Nina Shah et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma
Eric S. Yvon et al.
CYTOTHERAPY (2017)
Reduction in C-reactive protein indicates successful targeting of the IL-1/IL-6 axis resulting in improved survival in early stage multiple myeloma
John A. Lust et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial
Dean A. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
Jae H. Park et al.
BLOOD (2016)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
Jeremiah L. Oyer et al.
CYTOTHERAPY (2016)
CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection
Alexander Roelle et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
CIS is a potent checkpoint in NK cell-mediated tumor immunity
Rebecca B. Delconte et al.
NATURE IMMUNOLOGY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele
Caroline Jochems et al.
ONCOTARGET (2016)
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
Helen M. Parry et al.
ONCOTARGET (2016)
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
Peter S. Kim et al.
ONCOTARGET (2016)
Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
Yaewon Yang et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Natural Regulators: NK Cells as Modulators of T Cell immunity
Iona S. Schuster et al.
FRONTIERS IN IMMUNOLOGY (2016)
Licensed and Unlicensed NK Cells: Differential Roles in Cancer and viral Control
Megan M. Tu et al.
FRONTIERS IN IMMUNOLOGY (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group
Katsuto Takenaka et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation
Zachary B. Davis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
Heinrich Schlums et al.
IMMUNITY (2015)
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
Jaewon Lee et al.
IMMUNITY (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Critical role of tumor microenvironment in shaping NK cell functions: implication of hypoxic stress
Meriem Hasmim et al.
FRONTIERS IN IMMUNOLOGY (2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
Jianfeng Han et al.
SCIENTIFIC REPORTS (2015)
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
Veronika Bachanova et al.
BLOOD (2014)
Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia
Kate Stringaris et al.
HAEMATOLOGICA (2014)
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion
Alexander Roelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cross-talks between natural killer cells and distinct subsets of dencritic cells
Guido Ferlazzo et al.
FRONTIERS IN IMMUNOLOGY (2014)
NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
Rizwan Romee et al.
BLOOD (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcRγ Deficiency
Tianxiang Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
Yun-Peng Peng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
Subhashis Sarkar et al.
PLOS ONE (2013)
Natural killer cell alloreactivity 10 years later
Andrea Velardi
CURRENT OPINION IN HEMATOLOGY (2012)
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
Martha Luevano et al.
HUMAN IMMUNOLOGY (2012)
NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice
Ci-U Chen et al.
LEUKEMIA (2012)
Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
E. Van Valckenborgh et al.
LEUKEMIA (2012)
HLA-C-Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Jeffrey M. Venstrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
Cheng Sun et al.
PLOS PATHOGENS (2012)
Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism
Suresh Veeramani et al.
BLOOD (2011)
Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
E. J. West et al.
BRITISH JOURNAL OF CANCER (2011)
Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition
Emilie Mamessier et al.
CANCER RESEARCH (2011)
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment
Federica Bozzano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
Kerry S. Campbell et al.
IMMUNOLOGY (2011)
Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
Joseph C. Sun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
Sandra Lopez-Verges et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Jan Spanholtz et al.
PLOS ONE (2010)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Cytokine-induced memory-like natural killer cells
Megan A. Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer
Andrew Wilber et al.
STEM CELLS (2007)
A method for genetic modification of human embryonic stem cells using electroporation
Magdaline Costa et al.
NATURE PROTOCOLS (2007)
Critical residues at the ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-Like protein
Agnieszka Kielczewska et al.
JOURNAL OF IMMUNOLOGY (2007)
Activation, coactivation, and costimulation of resting human natural killer cells
Yenan T. Bryceson et al.
IMMUNOLOGICAL REVIEWS (2006)
Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities
Richard Graeff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human NK cell education by inhibitory receptors for MHC class I
Nicolas Anfossi et al.
IMMUNITY (2006)
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
Marc Beyer et al.
BLOOD (2006)
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
M Gumá et al.
BLOOD (2006)
Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children
U Koehl et al.
KLINISCHE PADIATRIE (2005)
Licensing of natural killer cells by host major histocompatibility complex class I molecules
S Kim et al.
NATURE (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone et al.
BLOOD (2005)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism
KC Hsu et al.
IMMUNOLOGICAL REVIEWS (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
分享论文
